Medibank has announced changes to its executive leadership team, including the appointment of Felicia Trewin to head data and technology and Robert Read to lead Amplar Health.
Mr Read's appointment follows Dr Andrew Wilson’s decision to step back from the executive leadership team and take on the role of chief medical officer in a part-time capacity.
“I am excited to be welcoming Felicia and Rob to the executive leadership team. Together we are well positioned to grow and to deliver on our 2030 vision to achieve the best health and wellbeing for Australia," said CEO David Koczkar.
“Felicia brings with her significant experience in technology, large program delivery, security and transformation in financial services," he said.
Ms Trewin has been chief technology officer at AMP since March 2022 and has more than 25 years of experience in technology. Her appointment is effective in early 2024, with Kylie Williamson continuing to act in the role until that time.
“Rob joined Medibank last year and has broad experience in health, including delivering customer-led strategies, driving business growth and operational management," continued Mr Koczkar.
Mr Read joined Medibank in June 2022 as Amplar Health's chief commercial officer. Prior to that, he was CEO and managing director at MedAdvisor and has also held senior roles at GSK.
He will begin in the role on 13 November 2023.
“Together, Felicia and Rob will be instrumental in helping us continue to deliver for our customers," said Mr Koczkar.
“I am also very pleased Andrew will continue to contribute to our company after making the decision to step back from the executive leadership team after 13 years and take on the role of our Group Chief Medical Officer.
“Andrew has been fundamental in our transformation to a health company. I would like to thank Andrew for his contribution to Medibank and am personally looking forward to continuing to work with him in his new role as Group Chief Medical Officer," added Mr Koczkar.